{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:05:38Z","timestamp":1788174338261,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000924","name":"MS Research Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["FB GNT2016841"],"award-info":[{"award-number":["FB GNT2016841"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["SR GNT2008339"],"award-info":[{"award-number":["SR GNT2008339"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["RCD GNT1193648"],"award-info":[{"award-number":["RCD GNT1193648"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001047","name":"Ian Potter Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jneuroim.2025.578760","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T23:30:44Z","timestamp":1758151844000},"page":"578760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Live MOG-IgG cell-based assay: Comparison across flow cytometers and diagnostic validation on high-sensitivity full spectrum flow cytometry"],"prefix":"10.1016","volume":"409","author":[{"given":"Elisha","family":"Siwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asawin","family":"Tungpoomjaruswong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Merheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona X.Z.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhria","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Acebes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell C","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudarshini","family":"Ramanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Brilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578760_bb0005","doi-asserted-by":"crossref","first-page":"101944","DOI":"10.1016\/j.smim.2025.101944","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Insights into pathogenesis and biomarkers of prognosis","volume":"78","author":"Andersen","year":"2025","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578760_bb0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578760_bb0015","series-title":"Eurachem Guide: Terminology in Analytical Measurement\u2013Introduction to VIM 3 (Eurachem)","author":"Barwick","year":"2023"},{"key":"10.1016\/j.jneuroim.2025.578760_bb0020","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/ijlh.14098","article-title":"Full spectrum flow cytometry in the clinical laboratory","volume":"45","author":"Brestoff","year":"2023","journal-title":"Int. J. Lab. Hematol."},{"issue":"13","key":"10.1016\/j.jneuroim.2025.578760_bb0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/cells14130997","article-title":"Beyond the limits: how is spectral flow cytometry reshaping the clinical landscape and what is coming next?","volume":"14","author":"Czechowska","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578760_bb0030","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000012","article-title":"Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton","volume":"1","author":"Dale","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578760_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.clim.2010.11.013","article-title":"Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases","volume":"138","author":"Di Pauli","year":"2011","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578760_bb0040","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jnnp-2023-332851","article-title":"The MOG antibody non-P42 epitope is predictive of a relapsing course in MOG antibody-associated disease","volume":"95","author":"Liyanage","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578760_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jalm\/jfab101","article-title":"Validation of a flow cytometry live cell-based assay to detect myelin oligodendrocyte glycoprotein antibodies for clinical diagnostics","volume":"7","author":"Lopez","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.jneuroim.2025.578760_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642272","article-title":"Detection of MOG-IgG in clinical samples by live cell-based assays: performance of immunofluorescence microscopy and flow cytometry","volume":"12","author":"Marchionatti","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578760_bb0055","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","article-title":"Myelin-oligodendrocyte glycoprotein antibody-associated disease","volume":"20","author":"Marignier","year":"2021","journal-title":"Lancet Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578760_bb0060","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/jnnp-2024-335137","article-title":"Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study","volume":"96","author":"Marignier","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry."},{"issue":"21","key":"10.1016\/j.jneuroim.2025.578760_bb0065","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4155\/bio-2021-0201","article-title":"With great power comes great responsibility: high-dimensional spectral flow cytometry to support clinical trials","volume":"13","author":"McCausland","year":"2021","journal-title":"Bioanalysis"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578760_bb0070","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm1488","article-title":"Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein","volume":"13","author":"O\u2019Connor","year":"2007","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578760_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000040","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578760_bb0080","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"key":"10.1016\/j.jneuroim.2025.578760_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/bs.mcb.2024.02.022","article-title":"Spectral flow cytometry: fundamentals and future impact","volume":"186","author":"Robinson","year":"2024","journal-title":"Methods Cell Biol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578760_bb0090","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/acn3.52310","article-title":"Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assay","volume":"12","author":"Said","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578760_bb0095","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.868","article-title":"Flow cytometry method validation protocols","volume":"3","author":"Selliah","year":"2023","journal-title":"Curr. Protocols"},{"key":"10.1016\/j.jneuroim.2025.578760_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-019-0786-3","article-title":"Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination","volume":"7","author":"Tea","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jneuroim.2025.578760_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2020.00119","article-title":"Effects of the positive threshold and data analysis on human MOG antibody detection by live flow cytometry","volume":"11","author":"Tea","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578760_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103693","article-title":"MOGAD: a comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally","volume":"24","author":"Trewin","year":"2024","journal-title":"Autoimmun. Rev."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578760_bb0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/jnnp-2024-333463","article-title":"Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse","volume":"95","author":"Trewin","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578760_bb0120","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflam."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578760_bb0125","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825002413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:42:28Z","timestamp":1766086948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825002413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S0165572825002413"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578760","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Live MOG-IgG cell-based assay: Comparison across flow cytometers and diagnostic validation on high-sensitivity full spectrum flow cytometry","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578760"}}